» Articles » PMID: 33070904

Approach to Critical Illness Myopathy and Polyneuropathy in the Older SARS-CoV-2 Patients

Abstract

One of the major concerns of the health care community and the public surrounding the SARS-CoV-2 pandemic is the availability and use of ventilators. Unprecedented surges of patients presented to intensive care units across the country, with older adults making up a large proportion of the patient population. This paper illustrates contemporary approaches to critical illness myopathy (CIM), critical illness polyneuropathy (CIP), and critical illness polyneuromyopathy (CIPNM) in older patients, including incidence, risk factors, mechanisms for pathology, diagnosis, contemporary treatment approaches, and outcomes. We hope that the following analysis may help educate clinicians and ultimately decrease the duration of the mechanical ventilation required by these patients, resulting in improved clinical outcomes and an increase in ventilator availability for other patients in need.

Citing Articles

Potential diagnostic tools for intensive care unit acquired weakness: A systematic review.

Xin C, Gai Y, Wei L, Wang Y, Luo Y, Han B Int J Nurs Stud Adv. 2025; 8:100301.

PMID: 39995749 PMC: 11849193. DOI: 10.1016/j.ijnsa.2025.100301.


Baseline Characteristics and Outcomes for People With and Without COVID-19 Diagnoses Receiving Inpatient Rehabilitation Care Across the US in 2020-2021.

Charbonneau E, Grover P, Johns J, McDowell S, Stillo J Arch Rehabil Res Clin Transl. 2023; 5(3):100281.

PMID: 37744204 PMC: 10517355. DOI: 10.1016/j.arrct.2023.100281.


Comparing Neuro-COVID-19 between Waves Requires Clear Cohort Selection.

Finsterer J, Scorza F Ann Indian Acad Neurol. 2023; 26(3):304-305.

PMID: 37538437 PMC: 10394432. DOI: 10.4103/aian.aian_11_23.


Short-Term Outcomes of the First-Session Prone Position in Patients With Severe Coronavirus Disease 2019: A Retrospective Chart Review.

Onji M, Kakizoe S, Nakai A, Shimizu K, Masui Y, Naito K Cureus. 2023; 15(2):e35437.

PMID: 36994294 PMC: 10041127. DOI: 10.7759/cureus.35437.


Intensive care unit-acquired weakness: A review from molecular mechanisms to its impact in COVID-2019.

Gonzalez A, Abrigo J, Achiardi O, Simon F, Cabello-Verrugio C Eur J Transl Myol. 2022; 32(3).

PMID: 36036350 PMC: 9580540. DOI: 10.4081/ejtm.2022.10511.


References
1.
Waclawik A, Sufit R, Beinlich B, Schutta H . Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium. Neuromuscul Disord. 1992; 2(1):19-26. DOI: 10.1016/0960-8966(92)90022-x. View

2.
Jung B, Moury P, Mahul M, De Jong A, Galia F, Prades A . Diaphragmatic dysfunction in patients with ICU-acquired weakness and its impact on extubation failure. Intensive Care Med. 2015; 42(5):853-861. DOI: 10.1007/s00134-015-4125-2. View

3.
Piva S, Fagoni N, Latronico N . Intensive care unit-acquired weakness: unanswered questions and targets for future research. F1000Res. 2019; 8. PMC: 6480958. DOI: 10.12688/f1000research.17376.1. View

4.
Koch S, Spuler S, Deja M, Bierbrauer J, Dimroth A, Behse F . Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge. J Neurol Neurosurg Psychiatry. 2010; 82(3):287-93. DOI: 10.1136/jnnp.2009.192997. View

5.
Tseng C, Perrone L, Zhu H, Makino S, Peters C . Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection. J Immunol. 2005; 174(12):7977-85. DOI: 10.4049/jimmunol.174.12.7977. View